Factors affecting thermal stability of collagen from the aspects of extraction, processing and modification
10.1007/978-3-319-47754-1_10 168 RomoliniG.GambucciM.RicciarelliD.TarpaniL.ZampiniG.LatteriniL
Alok Malik, president and business head, India formulations, at Glenmark Pharmaceuticals, said a big challenge in GLP-1 therapies is to ensure patients are able to start and stay on treatment
The short answer: semaglutide doesn't treat Cushing's itself, but it can meaningfully support weight loss after the cortisol excess is resolved
The most probable scenario is that compounding pharmacies would be permitted to produce certain peptides under FDA oversight, allowing licensed health-care professionals to prescribe them. This would be similar to what happened with semaglutide, the active ingredient in GLP-1 medications like Ozempic, he says